HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yo Matsuo Selected Research

Biomarkers (Surrogate Marker)

4/2016Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yo Matsuo Research Topics

Disease

14Neoplasms (Cancer)
08/2018 - 01/2003
2Breast Neoplasms (Breast Cancer)
08/2018 - 12/2012
2Carcinogenesis
07/2017 - 11/2016
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2017 - 03/2016
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2015 - 12/2014
1Stomach Neoplasms (Stomach Cancer)
07/2017
1Squamous Cell Carcinoma of Head and Neck
01/2017
1Kidney Neoplasms (Kidney Cancer)
04/2016
1Leukemia
12/2014
1Hematologic Neoplasms (Hematological Malignancy)
12/2014
1Triple Negative Breast Neoplasms
10/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2012
1Proteostasis Deficiencies
09/2008
1Ovarian Neoplasms (Ovarian Cancer)
03/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2004
1Asthma (Bronchial Asthma)
02/2004

Drug/Important Bio-Agent (IBA)

7Phosphotransferases (Kinase)IBA
01/2017 - 12/2012
5Protein Kinases (Protein Kinase)IBA
03/2017 - 10/2014
4OTS167IBA
04/2016 - 12/2014
3Lysine (L-Lysine)FDA Link
08/2018 - 11/2016
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2017 - 11/2016
2Proteins (Proteins, Gene)FDA Link
01/2017 - 09/2008
2AntigensIBA
03/2004 - 02/2004
1Histones (Histone)IBA
08/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2018
1Protein MethyltransferasesIBA
08/2018
1CateninsIBA
08/2017
1Histone-Lysine N-MethyltransferaseIBA
07/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2017
1Protein Kinase InhibitorsIBA
03/2017
1Tyrosine (L-Tyrosine)FDA Link
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2017
1Threonine (L-Threonine)FDA Link
11/2016
1Biomarkers (Surrogate Marker)IBA
04/2016
1Forkhead Box Protein M1IBA
04/2016
1OTS514IBA
04/2016
1Differentiation AntigensIBA
03/2016
1Small Interfering RNA (siRNA)IBA
03/2016
1SolutionsIBA
03/2004
1SerpinsIBA
02/2004
1OvalbuminIBA
02/2004
1Interleukin-13IBA
02/2004
1CytokinesIBA
02/2004
1Interleukin-4 (Interleukin 4)IBA
02/2004
1Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
01/2003

Therapy/Procedure

4Therapeutics
08/2018 - 12/2014
1Aftercare (After-Treatment)
08/2017
1Molecular Targeted Therapy
01/2017
1Oral Administration
12/2012